Lilly Stock Jumps After Phase 3 Weight-Drug Readout
Lilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
Base value in index level serves as an anchor point for comparisons across periods, clarifying gains, losses, and scale.
23,806 articlesLilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
When a beloved soap star hints at a fragile return, it isn’t just headlines that shake. It can ripple into budgets, i...
Broadcom faced a sharp earnings-driven selloff, tumbling about 14% in a single day. This article spotlights an under-...
Bezos liquidated more than 1.25 million Amazon shares in early May 2026 via prearranged plans as he continues funding...
Helius has announced the acquisition of Light Protocol, a move designed to expand on-chain privacy within the Solana ...
Micron Technology jumped on a bold target upgrade, lifting questions about sustainability as the AI memory cycle fuel...
Investing often tempts us to cash in quick wins for the next big gain. This guide shows why you should think twice be...
A blockchain-focused stock fund is up about 11% year-to-date while Bitcoin slides about 29%, signaling a shift in how...
As workers start removing Trump’s name from the Kennedy Center, the nation’s capital watches a symbolic change that c...
A retail investor endured an 80% drawdown in a 3X semiconductor ETF, then capitalized on an AI-fueled rebound to turn...
A 63-year-old, single worker faces the classic Social Security dilemma: claim now for $1,750 monthly or delay to 70 f...
Moderna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...